Arizona Tribune - Boulevard

NYSE - LSE

RYCEF	-2.59%	18.16	$
RBGPF	1.57%	61.3	$
CMSC	0.18%	22.15	$
BTI	1.03%	61.375	$
RELX	0.35%	31.32	$
NGG	0.37%	81.875	$
AZN	1.37%	183.53	$
RIO	-1.65%	94.03	$
BP	-3.68%	37.935	$
VOD	-1.41%	13.855	$
GSK	-1.54%	51.28	$
BCE	0.09%	23.06	$
BCC	6.24%	76.575	$
JRI	-0.12%	12.615	$
CMSD	0.09%	21.98	$

Featured

No price shock for 'GTA VI' as gamers gear up for preorders

Gamers impatient for "Grand Theft Auto VI" to hit consoles in November learned Wednesday they will not face a widely-anticipated price shock, as developer Rockstar Games announced details of preorders set to open at midnight on Thursday.

'Inhumane': Gaza flotilla activists recount Israeli detention ordeal

Cracked bones, humiliation, sexual assault: Pro-Palestinian activists recounted the abuse they say they suffered from Israeli authorities for taking part in a Gaza-bound aid flotilla last month, which has sparked multiple investigations and international outcry.

Last news

Polaris Renewable Energy Announces Q4 and Annual 2025 Investor Call Details

TORONTO, ONTARIO / ACCESS Newswire / January 13, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") is pleased to announce it will be holding its Earnings Conference Call and Webcast to report its Q4 and annual 2025 Earnings Results on Thursday, February 19th, 2026, at 10:00 am EST.

NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave - NV-387 is Effective Against H3N2

SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, declares that the current severe influenza wave demonstrates the clear need for broad-spectrum antivirals that can work against all influenza viruses, as well as the seasonal respiratory viruses including RSV and Coronaviruses.

GridAI's Role at the Center of Grid Intelligence Economics

BOCA RATON, FL / ACCESS Newswire / January 13, 2026 / Infrastructure narratives are easy to tell. Execution narratives are harder, and far more revealing.

Vheda Health Closes Record 2025 with Market-Leading Outcomes, New Partnerships, and Workforce Growth

In 2025, Vheda Health achieved its largest growth on record - launching its chronic, behavioral health, and maternity programs across six new markets - driving 2,001% revenue growth and a 4,049% membership increase since 2021 through consistent 80%+ engagement and double-digit medical cost savings, reinforcing its leadership as the premier virtual health engagement solution for Medicaid, Medicare, and SNP health plans.

Hawaii's Kilauea volcano puts on spectacular lava display

Hawaii's Kilauea was spraying a spectacular fountain of lava on Monday, keeping up its reputation as one of the world's most active volcanoes.

US 'screwed' if Supreme Court rules against tariffs: Trump

President Donald Trump said Monday that the United States would be "screwed" if the Supreme Court rules that some of his tariffs are illegal.

Ex-Fed chiefs, lawmakers slam US probe into Jerome Powell

Former Federal Reserve chiefs sharply criticized on Monday a US criminal probe into current chair Jerome Powell, calling it an "unprecedented attempt" to undermine the central bank's independence.

Former Panama leader on trial over mega Latin America corruption scandal

Former Panamanian President Ricardo Martinelli went on trial on Monday for money laundering in a sprawling corruption case that has drawn in several South American leaders.

Paramount sues in hostile bid to buy Warner Bros Discover

Paramount Skydance said Monday that it filed a lawsuit against Warner Brothers Discovery (WBD) as it presses an unwelcomed bid to buy the CNN-parent company.

UK pays 'substantial' compensation to Guantanamo inmate: lawyer

The UK government has paid "substantial" compensation to a Guantanamo detainee who was tortured by the CIA and has been held there without charge for two decades, his lawyer said Monday.

Venezuela releases more political prisoners

Venezuela said Monday it had freed dozens more political prisoners as rights groups questioned the numbers and family members clamored for speedier releases after the US military ouster of long-term autocrat Nicolas Maduro.

Russian captain in fiery North Sea crash faces UK trial

The Russian captain of a cargo ship which hit a tanker in the North Sea off the UK coast triggering a huge fire was in court Monday for his trial charged with manslaughter for the death of a crew member.

Swiss inferno bar owner detained for three months

The co-owner of a Swiss bar which went up in flames during New Year celebrations has been placed in preventive detention for three months, a regional court said on Monday.

Georgia jails ex-PM for five years amid ruling party oustings

Georgia's former prime minister Irakli Garibashvili was jailed for five years Monday on money laundering charges, the prosecutor's office said, the latest in a sweeping shake-up of the country's ruling party as critics accuse it of drifting into Moscow's orbit.

Top UN court to hear Rohingya genocide case against Myanmar

Did Myanmar commit genocide against its Rohingya Muslim minority? That's what judges at the International Court of Justice will weigh during three weeks of hearings starting Monday.

Trump says Iran 'want to negotiate' after reports of hundreds killed in protests

US President Donald Trump said Sunday that Iran's leadership had called him seeking "to negotiate" after he repeatedly threatened to intervene militarily if Tehran killed protesters.

Hong Kong court hears sentencing arguments for Jimmy Lai

A Hong Kong court began hearing sentencing arguments on Monday for pro-democracy media tycoon Jimmy Lai, who was convicted of national security crimes that could land him in prison for life.

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an emerging leader in global cannabis cultivation and export, is pleased to provide a corporate update outlining recent developments and strategic plans for 2026.

Trustpoint Xposure Analysis Reveals How AI Tools Are Selecting One Company Instead of Many

Why AI Answer Engines Are Replacing Comparison With Elimination in Competitive Search

Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, CA / ACCESS Newswire / January 12, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, today announced that on January 8, 2026, the Compensation Committee of Revelation's Board of Directors approved an inducement grant consisting of 90,000 restricted stock units ("RSUs") covering 90,000 shares of the Company's common stock to a new non-executive employee. The RSUs were granted outside of the Company's stockholder-approved equity incentive plan. The award was granted as an inducement material to the employee's acceptance of employment with Revelation in accordance with Nasdaq Listing Rule 5635(c)(4).

Trustpoint Xposure is The Only AEO-Certified Agency Designed for AI- First Search.

As AI-powered search reshapes how people discover brands, Trustpoint Xposure is outlining why it operates as the only AEO-certified agency intentionally built for AI-first search, rather than adapted from traditional SEO or public relations models.

Trustpoint Xposure Sets Industry Standard as The Only AEO-certified PR Agency for AI Search

Trustpoint Xposure today announced its position as an AEO-certified PR agency, setting a new industry standard for how brands earn visibility, credibility, and citations in AI-powered search environments.

Jorie AI Introduces Clinically Driven Predictive Analytics to Support Proactive Care and Revenue Performance

Hospital-specific predictive analytics designed to identify risk earlier, improve outcomes, and significantly reduce costs

GridAI and the Financial Mechanics of Grid Intelligence

BOCA RATON, FL / ACCESS Newswire / January 12, 2026 / Grid intelligence only matters if it changes cost structures, creates new revenue streams, or both. Otherwise, it's just another layer of software observing problems it can't influence. The reason grid orchestration, and the companies providing it, have moved from theoretical discussion to an investable category is straightforward. The dollars involved are no longer marginal. They are large, recurring, and increasingly unavoidable.

Medical Care Technologies Inc. (OTC PINK:MDCE) 2026 Annual Shareholder Update and Strategic Roadmap

MESA, AZ / ACCESS Newswire / January 12, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology-focused company developing AI-driven consumer, wellness, and medical applications, today provided its 2026 annual shareholder update outlining its short-term, near-term, and long-term strategic goals as the Company advances its next phase of growth. These updates are also updated on our corporate website www.medicalcaretechnologies.com.

MDaudit Recognized as One of Modern Healthcare's Best in Business

WELLESLEY, MA / ACCESS Newswire / January 12, 2026 / MDaudit, an award-winning cloud-based continuous risk monitoring platform for healthcare revenue cycle management, is honored to be recognized by Modern Healthcare as one of the Best in Business of 2025. The annual program celebrates organizations that drive innovation, efficiency, and excellence, highlighting their pivotal role in enhancing the overall healthcare ecosystem.

Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity

Company demonstrates commercial-scale production of its Toll-like Receptor 5 (TLR5) agonist for Acute Radiation Syndrome (ARS) and Neutropenia through wholly owned contract development manufacturing organization (CDMO), Velocity BioworksCompany's next step is to initiate production under current Good Manufacturing Practice (cGMP), a critical milestone moving towards filing a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA)Milestone achieved in advance of January 26 TechWatch meeting with the Biomedical Advance Research and Development Authority (BARDA) to discuss federal strategic relevance of Entolimod™ for ARS

US Med-Equip Recognized as One of Modern Healthcare's Best in Business

Fast-Growing Rental Company Honored for Supply Chain Excellence Supporting Hospitals

Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million

$18M upfront payment to Jaguar ($16M upon deal closing and $2M upon completion of post-closing conditions)Up to additional $20M in milestone and other future paymentsFuture Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1Jaguar continues to be the manufacturer of Mytesi and Canalevia-CA1Meaningful non-dilutive capital enables Jaguar to focus on its rare-disease pipeline, which is the subject of ongoing BD discussions with other potential partners

CASI Pharmaceuticals Announces Update and Additional Results from Phase 1 Study of CID-103 in Adult Patients with Chronic Immune Thrombocytopenia

Additional proof of concept data consistent and strengthen data set shared at ASH 2025Management to host meetings at JP Morgan 44th Annual Healthcare Conference 2026

VSee Launches AI-Driven Rural Health Transformation Platform, Targeting Millions in Recaptured Revenue Per Hospital

VSee's Rapidly Configurable AI Telehealth Platform Addresses Rural Hospital Access and Financial Sustainability

GridAI: The Grid Is the New Battleground for AI Economics

BOCA RATON, FL / ACCESS Newswire / January 12, 2026 / For years, investors were trained to believe the bottleneck in artificial intelligence would be chips. Then it was talent. Then it was data. Each time, the market adjusted, capital flowed, and new winners emerged. What has changed quietly, but decisively, is where that constraint now lives.

Arizona Tribune - Boulevard (English)